PF573,228 inhibits vascular tumor cell growth, migration as well as angiogenesis, induces apoptosis and abrogates PRAS40 and S6RP phosphorylation

Mabeta, Peace

doi:10.1515/acph-2016-0031

Abstract

PF573,228 is a compound that targets focal adhesion kinase (FAK), a non-receptor protein kinase, which is over-expressed in various tumors. The aim of this study was to evaluate the effects of PF573,228 on the cells derived from mouse vascular tumors, namely, endothelioma cells.

The treatment of endothelioma cells with PF573,228 reduced their growth with an IC₅₀ of approximately 4.6 μmol L^-1 and inhibited cell migration with an IC₅₀ of about 0.01 μmol L^-1. Microscopic studies revealed morphological attributes of apoptosis. These observations were confirmed by ELISA, which showed increased caspase-3 activity. PF573,228 also inhibited angiogenesis in a dose-dependent manner, with an IC₅₀ of approximately 3.7 μmol L^-1, and abrogated the phosphorylation of cell survival proteins, proline-rich Akt substrate (PRAS40) and S6 ribosomal protein (S6RP). Array data further revealed that PF573,228 induced caspase-3 activation, thus promoting apoptosis. Since all the processes inhibited by PF573,228 provide important support to tumor survival and progression, the drug may have a potential role in the treatment of vascular tumors.

References

1. J. K. Slack-Davis, K. H. Martin, R. W. Tilghman, M. Iwanicki, E. J. Ung, C. Autry, M. J. Luzzio, B. Cooper, J. C. Kath, W. G. Roberts and J. T. Parsons, Cellular characterization of a novel focal adhesion kinase inhibitor, J. Biol. Chem. 282 (2007) 14845-14852; DOI: 10.1074/jbc.M606695200.10.1074/jbc.M606695200
Search in Google Scholar
2. M. J. van Nimwegen and B. van der Water, Focal adhesion kinase: A potential target in cancer therapy, Biochem. Pharmacol. 73 (2007) 597-609; DOI: 10.1016/j.bcp.2006.08.011.10.1016/j.bcp.2006.08.011
Search in Google Scholar
3. J. D. Hood and D. A. Cheresh, Role of integrins in cell invasion and migration, Nat. Rev. Cancer 2 (2002) 91-100; DOI: 10.1038/nrc727.10.1038/nrc727
Search in Google Scholar
4. T. Miyazaki, H. Kato, M. Nakajima, M. Sohda, Y. Fukai, N. Masuda, R. Manda, M. Fukuchi, K. Tsukada and H. Kuwano, FAK overexpression is correlated with tumour invasiveness and lymph node metastasis in oesophageal squamous cell carcinoma, Br. J. Cancer 89 (2003) 140-145; DOI: 10.1038/sj.bjc.6601050.10.1038/sj.bjc.6601050
Search in Google Scholar
5. J. T. Parsons, J. Slack-Davis, R. Tilghman and W. G. Roberts, Focal adhesion kinase: Targeting adhesion signaling pathways for therapeutic intervention, Clin. Cancer Res. 14 (2008) 627-632; DOI: 10.1158/1078-0432.CCR-07-2220.10.1158/1078-0432.CCR-07-2220
Search in Google Scholar
6. J. M. Stiles, R. K. Rowntree, C. Amaya, D. Diaz, V. Kokta, D. C. Mitchell and A. B. Brad, Gene expression analysis reveals marked differences in the transcriptome of infantile hemangioma endothelial cells compared to normal dermal microvascular endothelial cells, Vasc. Cell 5 (2013) 1-12; DOI: 10.1186/2045-824X-5-6.10.1186/2045-824X-5-6
Search in Google Scholar
7. L. V. Owens, L. Xu, G. A. Dent, X. Yang, G. C. Sturge, R. J. Craven and W. G. Cance, Focal adhesion kinase as a marker of invasive potential in differentiated human thyroid cancer, Ann. Surg. Oncol. 3 (1996) 100-105; DOI: 10.1007/BF02409059.10.1007/BF02409059
Search in Google Scholar
8. D. D. Schlaepfer, C. R. Hauck and D. J. Sieg, Signaling through focal adhesion kinase, Prog. Biophys. Mol. Biol. 71 (1999) 435-478; DOI: 10.1016/S0079-6107(98)00052-2.10.1016/S0079-6107(98)00052-2
Search in Google Scholar
9. L. A. Cohen and J. L. Guan, Mechanisms of focal adhesion kinase regulation, Curr. Cancer Drug Tar. 5 (2005) 629-643; DOI: 10.2174/156800905774932798.10.2174/15680090577493279816375667
Search in Google Scholar
10. P. Mabeta and M. S. Pepper, Inhibition of hemangioma development in a syngeneic mouse model correlates with Bcl-2 suppression and the inhibition of Akt kinase activity, Angiogenesis 15 (2012) 131-139; DOI: 10.10007/s10456-011-9248-7.
Search in Google Scholar
11. H. P. Gerber, A. McMurtrey, J. Kowalski, M. Yan, B. A. Keyt, V. Dixit and N. Ferrara, Vascular endothelial growth factor regulates endothelial cell survival through the phosphatidylinositol 3’-kinase/Akt signal transduction pathway. Requirement for Flk-1/KDR activation, J. Biol. Chem. 273 (1998) 30336-30343; DOI: 10.1074/jbc.273.46.30336.10.1074/jbc.273.46.303369804796
Search in Google Scholar
12. K. T. Sabapathy, M. S. Pepper, F. Kiefer, U. Möhle-Steinlein, F. Tacchini-Cottier, I. Fetka, G. Breier, W. Risau, P. Carmeliet, R. Montesano and E. F.Wagner, Polyoma middle T-induced vascular tumor formation: the role of the plasminogen activator/plasmin system, J. Cell Biol. 137 (1997) 953-963; DOI: 10.1083/jcb.137.4.953.10.1083/jcb.137.4.95321398399151696
Search in Google Scholar
13. P. Mabeta and M. S. Pepper, Altered expression of platelet factor 4 and basic fibroblast growth factor correlates with the inhibition of tumor growth in mice, Biomed. Pharmacol. 69 (2015) 186-190; DOI: 10.1016/j.biopha.2014.11.018.10.1016/j.biopha.2014.11.01825661356
Search in Google Scholar
14. M. A. Cabrita, L. M. Jones, J. L. Quizi, L. A. Sabourin, B. C. McKay and C. L. Addison, Focal adhesion kinase inhibitors are potent anti-angiogenic agents, Mol. Oncol. 5 (2011) 517-526; DOI: 10.1016/ jmolonc.2011.10.004.10.1016/j.molonc.2011.10.004552832022075057
Search in Google Scholar
15. S. Hiscox, P. Barnfather, E. Hayes, P. Bramble, J. Christensen, R. I. Nicholson and P. Barrett-Lee, Inhibition of focal adhesion kinase suppresses the adverse phenotype of endocrine-resistant breast cancer cells and improves endocrine response in endocrine-sensitive cells, Breast Cancer Res. Treat. 125 (2011) 659-669; DOI: 10.1007/s10549-010-0857-4.10.1007/s10549-010-0857-420354780
Search in Google Scholar
16. P. W. Bryant, Q. Zheng and K. M. Pumiglia, Focal adhesion kinase is a phospho-regulated repressor of Rac and proliferation in human endothelial cells, Biol. Open 15 (2012) 723-730; DOI: 10.1242/ bio.20121008.10.1242/bio.20121008350722523213465
Search in Google Scholar
17. L. Portt, G. Norman, C. Clapp, M. Greenwood and M. T. Greenwood, Anti-apoptosis and cell survival: A review, Biochim. Biophys. Acta 1813 (2011) 238-259; DOI: 10.1016/j.bbamcr.2010.10.010.10.1016/j.bbamcr.2010.10.01020969895
Search in Google Scholar
18. X. Zhao and J. L. Guan, Focal adhesion kinase and its signaling pathways in cell migration and angiogenesis, Adv. Drug Deliver. Rev. 63 (2011) 610-615; DOI: 10.1016/j.addr.2010.11.001.10.1016/j.addr.2010.11.001313282921118706
Search in Google Scholar
19. S. K. Mitra, D. A. Hanson and D. D. Schlaepfer. Focal adhesion kinase: in command and control of cell motility, Nat. Rev. Mol. Cell Biol. 6 (2005) 56-68; DOI: 10.1038/nrm1549.10.1038/nrm154915688067
Search in Google Scholar
20. B. Tavora, S. Batista, L. Reynolds, S. Jadeja, S. Robinson, V. Kostourou, I. Hart, M. Fruttiger, M. Parsons and K. M. Hodivala-Dilke, Endothelial FAK is required for tumour angiogenesis, EMBO Mol. Med. 2 (2010) 516-528; DOI: 10.1002/emmm.201000106.10.1002/emmm.201000106337734421154724
Search in Google Scholar
21. L. H. Xu, X. Yang, C. A. Bradham, D. A. Brenner, J. A. S. Baldwin, R. J. Craven and W. G. Cance, The focal adhesion kinase suppresses transformation-associated, anchorage-independent apoptosis in human breast cancer cells, J. Biol. Chem. 275 (2000) 30597-30604; DOI: 10.1074/jbc. M910027199. 10.1074/jbc
Search in Google Scholar
22. C. Wiza, E. B. M. Nascimento and D. M. Ouwens, Role of PRAS40 in Akt and mTOR signaling in health and disease, Am. J. Physiol. Endocrinol. Metab. 302 (2012) E1453-E1460; DOI: 10.1152/ajpendo.00660.2011.10.1152/ajpendo.00660.201122354785
Search in Google Scholar
23. H. Wang, Q. Zhang, Q. Wen, Y. Zheng, L. Philip, H. Jiang, J. Lin and W. Zheng, Proline-rich Akt substrate of 40 kDa (PRAS40): A novel downstream target of P13k/Akt signaling pathway, Cell Signal. 24 (2012) 17-24; DOI: 10.1016/j.cellsig.2011.08.010.10.1016/j.cellsig.2011.08.01021906675
Search in Google Scholar
24. I. Ruvinsky, N. Sharon, T. Lerer, H. Cohen, M. Stolovich-Rain, T. Nir, Y. Dor, P. Zisman and O. Meyuhas, Ribosomal protein S6 phosphorylation is a determinant of cell size and glucose homeostasis, Genes Dev. 19 (2005) 2199-2211; DOI: 10.1101/gad.351605.10.1101/gad.351605122189016166381
Search in Google Scholar
25. B. Gan, Y. Yoo and J. Guan, Association of focal adhesion kinase with tuberous sclerosis complex 2 in the regulation of S6 kinase activation and cell growth, J. Biol. Chem. 281 (2006) 37321-37329; DOI: 10.1074/jbc.M605241200.10.1074/jbc.M60524120017043358
Search in Google Scholar
26. A. Porras and C. Guerrero, Role of p38α in apoptosis: Implication in cancer development and therapy, Atlas Genet. Cytogenet. Oncol. Haematol. 15 (2011) 316-326; DOI: 10.4267/2042/44993.10.4267/2042/44993
Search in Google Scholar

PF573,228 inhibits vascular tumor cell growth, migration as well as angiogenesis, induces apoptosis and abrogates PRAS40 and S6RP phosphorylation

Abstract

Paradigm

My account